Home

Therapeutic Proteins Companies and Organizations

Included core activities: Therapeutic Proteins (18)
The number in () indicates the number of employers worldwide

21 Locations

18 Employers

Amarantus Therapeutics

Business Area(s): 
Description: 
Therapeutic Proteins

Ambrx

Business Area(s): 
Description: 

Ambrx uses Protein Medicinal Chemistry™ to modify proteins or antibodies to create potentially best-in-class protein therapeutics.

Amunix

Business Area(s): 
Description: 
Therapeutic Proteins

aTyr Pharma

Business Area(s): 
Description: 
Therapeutic Proteins

Belrose Pharma

Business Area(s): 
Description: 

Belrose Pharma focuses on rare diseases and uses its proprietary “releasable linker” conjugation technology and other techniques to improve the clinical efficacy of both novel therapeutics and ...

ContraFect

Business Area(s): 
Description: 

ContraFect is a clinical stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies for life-threatening, drug-resistant infectious diseases, ...

Curna (Opko)

Business Area(s): 
Description: 

 

OPKO-CURNA is developing a unique therapeutic modality focusing on the targeted up-regulation of protein levels via the targeted up-regulation of gene expression.

DesigneRx Pharmaceuticals

Business Area(s): 
Description: 

DesignerRx produces novel protein therapeutics to treat cancer and other debilitating diseases in humans.

Ethris

Business Area(s): 
Description: 

Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Their integrated platform enables the discovery, design and development of ...

Five Prime Therapeutics

Business Area(s): 
Description: 

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases

Icogenex

Business Area(s): 
Description: 

Protein Therapeutics

Morphic Therapeutic

Business Area(s): 
Description: 

Working to develop the first orally administered integrin therapeutics for patients with immunological, fibrotic, neoplastic, and vascular diseases.

NeuClone

Business Area(s): 
Description: 

NeuClone works on upstream development of biosimilars including mammalian cell line development and the analytics required to confirm biosimilarity.

Omeros

Business Area(s): 
Description: 

Small Molecules, vision and ocular related diseases, and Huntington's disease treatments

Protein Genomics

Business Area(s): 
Description: 

Protein Genomics carries out research and development on sophisticated, high performance biopolymers for potential applications in the wound healing, tissue regeneration, dermal filler and ...

Resolve Therapeutics

Business Area(s): 
Description: 

The company works on technologies to treat lupus and Sjögren’s disease byremoving inflammatory molecules. Develops Fc - nuclease fusion proteins.

 

Therachon

Business Area(s): 
Description: 

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is ...

Versartis

Business Area(s): 
Description: 
Therapeutic Proteins
Don't see an employer? Please fill out the form